Related Experiment Video
Updated: Jan 4, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Ultrasmall Renally Clearable Silica Nanoparticles Target Prostate Cancer
1Department of Materials Science & Engineering , Cornell University , Ithaca , New York 14853 , United States.
Abstract:
Although important advances have been achieved in the development of radiolabeled prostate-specific membrane antigen (PSMA)-targeting ligand constructs for both diagnosis and therapy of prostate cancer (PCa) over the past decade, challenges related to off-target effects and limited treatment responses persist. In this study, which builds upon the successful clinical translation of a series of ultrasmall, dye-encapsulating core-shell silica nanoparticles, or Cornell Prime Dots (C' dots), for cancer management, we sought to address these limitations by designing a dual-modality, PSMA-targeting platform that evades undesirable accumulations in the salivary glands, kidneys, and reticuloendothelial system, while exhibiting bulk renal clearance. This versatile PCa-targeted particle imaging probe offers significant clinical potential to improve future theranostic applications in a variety of patient care settings.
Insights
Researchers developed a new dual-modality, prostate-specific membrane antigen (PSMA)-targeting nanoparticle to improve prostate cancer (PCa) diagnosis and therapy. This novel platform minimizes off-target effects and enhances clearance, offering improved theranostic applications.
Area of Science:
- Nanomedicine
- Radiochemistry
- Oncology
Background:
- Advances in radiolabeled prostate-specific membrane antigen (PSMA)-targeting ligands for prostate cancer (PCa) diagnosis and therapy exist.
- Challenges persist regarding off-target effects and limited treatment responses.
Purpose of the Study:
- To address limitations of current PSMA-targeting ligands.
- To design a dual-modality, PSMA-targeting platform using ultrasmall core-shell silica nanoparticles (Cornell Prime Dots, C' dots).
- To achieve bulk renal clearance and evade accumulation in salivary glands, kidneys, and reticuloendothelial system.
Main Methods:
- Utilized ultrasmall, dye-encapsulating core-shell silica nanoparticles (C' dots).
- Engineered a dual-modality, PSMA-targeting platform.
- Evaluated nanoparticle accumulation and clearance profiles.
Main Results:
- The developed platform demonstrated evasion of undesirable accumulations in off-target organs.
- The nanoparticles exhibited bulk renal clearance.
- The C' dot platform showed potential for improved theranostic applications.
Conclusions:
- The novel dual-modality, PSMA-targeting C' dot platform offers a promising solution to current challenges in PCa theranostics.
- This versatile probe has significant clinical potential for improving patient care settings.
